Serum Institute of India (SII) has applied for emergency use authorization of Covishield, the Covid-19 vaccine developed by pharmaceutical company AstraZeneca and Oxford University.
Serum Institute of India (SII) has applied for emergency use authorization of Covishield, the Covid-19 vaccine developed by pharmaceutical company AstraZeneca and Oxford University.